BIOmarkers Before and After Kidney Transplantation
Diagnostic and PROgnostic BIOmarkers Before and After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris
1,000 participants
Oct 8, 2024
OBSERVATIONAL
Conditions
Summary
In clinical nephrology, the search for urinary, blood and tissue biomarkers of specific kidney diseases is an important goal. In recent years, the use of these biomarkers has made it possible to diagnose many renal diseases that affect the native kidney. In some cases, biomarkers may be useful in determining the evolutionary profile of the disease and thus the most appropriate therapeutic management.
Eligibility
Inclusion Criteria4
- Patient hospitalised for renal biopsy of a native kidney or for renal transplantation
- Age \>18 years
- Informed and consented
- Covered by a social security scheme
Exclusion Criteria4
- Patients under guardianship, conservatorship or legal protection
- Pregnant or breastfeeding
- Patient deprived of liberty
- Patients of legal age who are unable to give consent
Interventions
blood sample during standard of care visit for a native kidney biopsy (17.5mL)
blood sample during standard of care visit for a renal graft biopsy (17.5mL)
Urine sample during standard of care visit for a renal graft biopsy (50mL)
Urine sample during standard of care visit for a native kidney biopsy (50mL)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06810258